Leica Biosystems, a provider of anatomic and digital pathology solutions, has announced a strategic investment in Indica Labs, a company specializing in AI-powered digital pathology software. The collaboration aims to advance AI-enabled companion diagnostics (CDx) and support breakthroughs in biomarker analysis for cancer and other conditions. As part of the agreement, Leica Biosystems and Indica…